Wellington Management Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $358M | Buy |
|
|||||
|
2025
Q2 | $158M | Buy |
|
|||||
|
2025
Q1 | $91.6M | Sell |
|
|||||
|
2024
Q4 | $96.9M | Sell |
|
|||||
|
2024
Q3 | $188M | Sell |
|
|||||
|
2024
Q2 | $356M | Sell |
|
|||||
|
2024
Q1 | $415M | Sell |
|
|||||
|
2023
Q4 | $409M | Sell |
|
|||||
|
2023
Q3 | $307M | Buy |
|
|||||
|
2023
Q2 | $281M | Buy |
|
|||||
|
2023
Q1 | $315M | Sell |
|
|||||
|
2022
Q4 | $373M | Sell |
|
|||||
|
2022
Q3 | $379M | Buy |
|
|||||
|
2022
Q2 | $330M | Sell |
|
|||||
|
2022
Q1 | $548M | Buy |
|
|||||
|
2021
Q4 | $548M | Buy |
|
|||||
|
2021
Q3 | $629M | Buy |
|
|||||
|
2021
Q2 | $452M | Sell |
|
|||||
|
2021
Q1 | $450M | Buy |
|
|||||
|
2020
Q4 | $567M | Buy |
|
|||||
|
2020
Q3 | $502M | Buy |
|
|||||
|
2020
Q2 | $264M | Buy |
|
|||||
|
2020
Q1 | $188M | Sell |
|
|||||
|
2019
Q4 | $239M | Buy |
|
|||||
|
2019
Q3 | $76.5M | Buy |
|
|||||
|
2019
Q2 | $13.8M | Buy |
|
|||||
|
2019
Q1 | $12.9M | Buy |
|
|||||
|
2018
Q4 | $3.05M | Buy |
|
|||||
|
2018
Q3 | $3.06M | Sell |
|
|||||
|
2018
Q2 | $3.95M | Buy |
|
|||||
|
2018
Q1 | $1.15M | Buy |
|